Glytec’s eGMS centers on Glucommander™, the only cloud-based, FDA-cleared software able to personalize IV and SubQ insulin dosing support for patients with and without diabetes.
What do you need to know about these new glycemic management eCQMs and how will they impact hospitals’ people, process, technology, as well as their bottom lines?
This webinar explored how chief quality officers are preparing to measure and report the CMS’s latest electronic Clinical Quality Measures, released August 2021, and how they’ll leverage the opportunity to improve patient safety with a new focus on better glycemic management.
Thank you! Is your hospital ready for CMS’ glycemic management measures? Here’s your guide. Danielle Scheurer, MD, MSRC, SFHM | Medical University of South Carolina Jordan Messler, MD, SFHM, FACP | Glytec You’ll receive an email with a link to this video in case you want to watch it later. MAR-0000359 Rev 1.0 TRANSCRIPT: Hi, everyone, and welcome to today’s …
You’re Invited to Time to Target: Glycemic Innovation and Collaboration Summit A Message from John Downey, Chief Commercial Officer at Glytec Hi, I’m John Downey, the Chief Commercial Officer at Glytec. Glytec helps clinicians personalize insulin dosing for the roughly 40% of hospitalized patients whose care would benefit from insulin therapy. Earlier this month, CMS announced new quality metrics and …
CMS (US Centers for Medicare & Medicaid Services) released new rules for the FY22 fiscal year. This update includes changes to the Hospital Inpatient Quality-Reporting (IQR) Program, which requires healthcare facilities to capture and report electronic clinical quality measures (eCQMs).
Both hypoglycemia and hyperglycemia are correlated with increases in length of stay, cost of care and readmissions. This guide will discuss how your hospital can reduce the Incidence of hypoglycemia and hyperglycemia with the help of Glytec’s eGMS®.